ArticlePediatric blood & cancer2018

Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213).

Robin E Norris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.